It was also demonstrated that the LSD1 inhibitor, QC6352, suppressed tumor growth, sphere formation and proliferation of patient-derived BCSCs in a newly developed orthotopic xenograft model [212]. This evidence concerns the gene KDM1A and neoplasm.